Cargando…
Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study
INTRODUCTION: Studying post-vaccination side effects and identifying the reasons behind low vaccine uptake are pivotal for overcoming the pandemic. METHODS: This cross-sectional study was distributed through social media platforms and face-to-face interviews. Data from vaccinated and unvaccinated pa...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405764/ https://www.ncbi.nlm.nih.gov/pubmed/37544017 http://dx.doi.org/10.1080/07853890.2023.2241351 |
_version_ | 1785085606054854656 |
---|---|
author | Najjar, Michel Albuaini, Sara Fadel, Mohammad Mohsen, Fatema |
author_facet | Najjar, Michel Albuaini, Sara Fadel, Mohammad Mohsen, Fatema |
author_sort | Najjar, Michel |
collection | PubMed |
description | INTRODUCTION: Studying post-vaccination side effects and identifying the reasons behind low vaccine uptake are pivotal for overcoming the pandemic. METHODS: This cross-sectional study was distributed through social media platforms and face-to-face interviews. Data from vaccinated and unvaccinated participants were collected and analyzed using the chi-square test, multivariable logistic regression to detect factors associated with side effects and severe side effects. RESULTS: Of the 3509 participants included, 1672(47.6%) were vaccinated. The most common reason for not taking the vaccine was concerns about the vaccine’s side effects 815(44.4). The majority of symptoms were mild 788(47.1%), followed by moderate 374(22.3%), and severe 144(8.6%). The most common symptoms were tiredness 1028(61.5%), pain at the injection site 933(55.8%), and low-grade fever 684(40.9%). Multivariable logistic regression analysis revealed that <40 years (vs. ≥40; OR: 2.113, p-value = 0.008), females (vs. males; OR: 2.245, p-value< .001), did not receive influenza shot last year (vs. did receive Influenza shot last year OR: 1.697, p-value = 0.041), AstraZeneca (vs. other vaccine brands; OR: 2.799, p-value< .001), co-morbidities (vs. no co-morbidities; OR: 1.993, p-value = 0.008), and diabetes mellitus (vs. no diabetes mellitus; OR: 2.788, p-value = 0.007) were associated with severe post-vaccine side effects. Serious side effects reported were blood clots 5(0.3%), thrombocytopenia 2(0.1%), anaphylaxis 1(0.1%), seizures 1(0.1%), and cardiac infarction 1(0.1%). CONCLUSION: Our study revealed that most side effects reported were mild in severity and self-limiting. Increasing the public’s awareness of the nature of the vaccine’s side effects would reduce the misinformation and improve the public’s trust in vaccines. Larger studies to evaluate rare and serious adverse events and long-term side effects are needed, so people can have sufficient information and understanding before making an informed consent which is essential for vaccination. |
format | Online Article Text |
id | pubmed-10405764 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-104057642023-08-08 Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study Najjar, Michel Albuaini, Sara Fadel, Mohammad Mohsen, Fatema Ann Med Immunology INTRODUCTION: Studying post-vaccination side effects and identifying the reasons behind low vaccine uptake are pivotal for overcoming the pandemic. METHODS: This cross-sectional study was distributed through social media platforms and face-to-face interviews. Data from vaccinated and unvaccinated participants were collected and analyzed using the chi-square test, multivariable logistic regression to detect factors associated with side effects and severe side effects. RESULTS: Of the 3509 participants included, 1672(47.6%) were vaccinated. The most common reason for not taking the vaccine was concerns about the vaccine’s side effects 815(44.4). The majority of symptoms were mild 788(47.1%), followed by moderate 374(22.3%), and severe 144(8.6%). The most common symptoms were tiredness 1028(61.5%), pain at the injection site 933(55.8%), and low-grade fever 684(40.9%). Multivariable logistic regression analysis revealed that <40 years (vs. ≥40; OR: 2.113, p-value = 0.008), females (vs. males; OR: 2.245, p-value< .001), did not receive influenza shot last year (vs. did receive Influenza shot last year OR: 1.697, p-value = 0.041), AstraZeneca (vs. other vaccine brands; OR: 2.799, p-value< .001), co-morbidities (vs. no co-morbidities; OR: 1.993, p-value = 0.008), and diabetes mellitus (vs. no diabetes mellitus; OR: 2.788, p-value = 0.007) were associated with severe post-vaccine side effects. Serious side effects reported were blood clots 5(0.3%), thrombocytopenia 2(0.1%), anaphylaxis 1(0.1%), seizures 1(0.1%), and cardiac infarction 1(0.1%). CONCLUSION: Our study revealed that most side effects reported were mild in severity and self-limiting. Increasing the public’s awareness of the nature of the vaccine’s side effects would reduce the misinformation and improve the public’s trust in vaccines. Larger studies to evaluate rare and serious adverse events and long-term side effects are needed, so people can have sufficient information and understanding before making an informed consent which is essential for vaccination. Taylor & Francis 2023-08-06 /pmc/articles/PMC10405764/ /pubmed/37544017 http://dx.doi.org/10.1080/07853890.2023.2241351 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Immunology Najjar, Michel Albuaini, Sara Fadel, Mohammad Mohsen, Fatema Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study |
title | Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study |
title_full | Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study |
title_fullStr | Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study |
title_full_unstemmed | Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study |
title_short | Covid-19 vaccination reported side effects and hesitancy among the Syrian population: a cross-sectional study |
title_sort | covid-19 vaccination reported side effects and hesitancy among the syrian population: a cross-sectional study |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405764/ https://www.ncbi.nlm.nih.gov/pubmed/37544017 http://dx.doi.org/10.1080/07853890.2023.2241351 |
work_keys_str_mv | AT najjarmichel covid19vaccinationreportedsideeffectsandhesitancyamongthesyrianpopulationacrosssectionalstudy AT albuainisara covid19vaccinationreportedsideeffectsandhesitancyamongthesyrianpopulationacrosssectionalstudy AT fadelmohammad covid19vaccinationreportedsideeffectsandhesitancyamongthesyrianpopulationacrosssectionalstudy AT mohsenfatema covid19vaccinationreportedsideeffectsandhesitancyamongthesyrianpopulationacrosssectionalstudy AT covid19vaccinationreportedsideeffectsandhesitancyamongthesyrianpopulationacrosssectionalstudy |